nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant or neoadjuvant therapeutic strategy for resectable non-small cell lung cancer
|
Hayashi, Ryuji |
|
|
61 |
2 |
p. 133-134 |
artikel |
2 |
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment
|
Narita, Daisuke |
|
|
61 |
2 |
p. 247-253 |
artikel |
3 |
Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases
|
Yamaya, Mutsuo |
|
|
61 |
2 |
p. 270-283 |
artikel |
4 |
Appreciation to Reviewers
|
|
|
|
61 |
2 |
p. I-II |
artikel |
5 |
Cardiovascular safety of genetically proxied interleukin-5 inhibition: A mendelian randomization study
|
Alton, Philip |
|
|
61 |
2 |
p. 149-152 |
artikel |
6 |
Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study
|
Miyamoto, Atsushi |
|
|
61 |
2 |
p. 284-295 |
artikel |
7 |
Clinical characteristics, outcomes, and factors associated with mortality in Nocardia pneumonia: 18 years' real-world data from a tertiary care hospital in Karachi, Pakistan
|
Rahim, Yasmin |
|
|
61 |
2 |
p. 254-260 |
artikel |
8 |
Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity
|
Kono, Masato |
|
|
61 |
2 |
p. 210-219 |
artikel |
9 |
COVID-19 symptom-onset to diagnosis and diagnosis to treatment intervals are significant predictors of disease progression and hospitalization in high-risk patients: A real world analysis
|
Shimizu, Hideyasu |
|
|
61 |
2 |
p. 220-229 |
artikel |
10 |
COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan
|
Kobayashi, Masanori |
|
|
61 |
2 |
p. 230-239 |
artikel |
11 |
Database analysis of hypersensitivity pneumonitis in Japan
|
Yamashita, Shohei |
|
|
61 |
2 |
p. 172-180 |
artikel |
12 |
Detection of impaired gas exchange using the 1-minute sit-to-stand test in patients with interstitial lung disease
|
Oishi, Keiji |
|
|
61 |
2 |
p. 186-189 |
artikel |
13 |
Efficacy of blonanserin transdermal patch on terminal delirium in patients with respiratory diseases
|
Ando, Katsutoshi |
|
|
61 |
2 |
p. 240-246 |
artikel |
14 |
Fixation rate of fiducial gold markers in each segmental bronchus for stereotactic body radiotherapy
|
Imasaka, Keisuke |
|
|
61 |
2 |
p. 190-199 |
artikel |
15 |
IFN-λ3 and CCL17 as predictors of disease progression in patients with mild to moderate COVID-19: A cohort study in a real-world setting
|
Sekimoto, Yasuhito |
|
|
61 |
2 |
p. 153-156 |
artikel |
16 |
IgA vasculitis as an immune-related adverse event of durvalumab: A case report
|
Kawataki, Masanori |
|
|
61 |
2 |
p. 205-209 |
artikel |
17 |
Marital status and post-COVID-19 conditions
|
Kudoh, Ryohei |
|
|
61 |
2 |
p. 181-185 |
artikel |
18 |
Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease
|
Matsuyama, Masashi |
|
|
61 |
2 |
p. 135-148 |
artikel |
19 |
Pleural plaque identification in computed tomography and intraoperative thoracic findings: Correspondence and prognosis comparison in patients with resection of non-small cell lung cancer
|
Kagimoto, Atsushi |
|
|
61 |
2 |
p. 200-204 |
artikel |
20 |
Real-world evaluation of asthma reliever therapy among continuous users of asthma maintenance medication in Japan: A retrospective cohort study using a claims database
|
Hozawa, Soichiro |
|
|
61 |
2 |
p. 164-171 |
artikel |
21 |
Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial
|
Kotb, Shady |
|
|
61 |
2 |
p. 261-269 |
artikel |
22 |
Virtual fluoroscopic preprocedural planning using Ziostation2 for transbronchial biopsy: A prospective self-controlled study
|
Abe, Yuko |
|
|
61 |
2 |
p. 157-163 |
artikel |